Ketonal (Ketoprofen)

Ketoprofen blocks both COX‑1 and COX‑2 enzymes, reducing the production of prostaglandins that mediate inflammation, pain, and fever. By lowering prostaglandin levels, it diminishes peripheral sensitisation and provides analgesic and anti‑inflammatory effects.

The specific dose and frequency of Ketonal are determined by the prescribing clinician based on the patient’s condition, severity of pain, and individual health factors. Dosage adjustments are made according to clinical response and safety considerations.

Ketonal is generally avoided during pregnancy and lactation unless the potential benefit justifies the risk. Limited data exist, and clinicians usually consider alternative therapies for pregnant or nursing individuals.

To request Ketonal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Ketonal (ketoprofen) offers a potent anti‑inflammatory effect comparable to ibuprofen or diclofenac, but its injectable form allows rapid onset for acute pain management. Its safety profile is similar to other non‑selective NSAIDs, with comparable gastrointestinal and cardiovascular risks.

Ketonal should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Maintaining the cold chain preserves the stability and sterility of the injectable solution.

Ketonal is supplied as a sterile injectable solution and is given either intramuscularly or intravenously by a qualified healthcare professional. The route, volume and rate of administration are determined by the prescriber.

Serious risks include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, acute renal failure, hepatic injury, anaphylaxis, and increased risk of cardiovascular thrombotic events. Prompt medical attention is required if any of these occur.

Ketonal is contraindicated in patients with known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal ulceration, severe renal or hepatic impairment, and in individuals with established cardiovascular disease where NSAID use is discouraged. Clinicians should assess each patient’s medical history before prescribing.